5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
104 lines
6.1 KiB
Markdown
104 lines
6.1 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68."
|
||
description: "Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68."
|
||
jurisdiction: "us/states/tn"
|
||
legislature: "Tennessee General Assembly"
|
||
session: "112"
|
||
identifier: "SB 2240"
|
||
citation: "Tennessee SB 2240 (112)"
|
||
classification: ["bill"]
|
||
subjects: ["Controlled Substances"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Haile", "Vaughan"]
|
||
version_count: 3
|
||
action_count: 41
|
||
vote_count: 6
|
||
first_action: "2022-02-01"
|
||
last_action: "2022-04-26"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/ca27ad67-6053-443c-aa7b-ecef232244bc"
|
||
source_url: "http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB2240&GA=112"
|
||
source_hash: "4582e66c64942ad1bcde02c13f501cf7dcd8aaa43863f5b0b0be64c43f7aa80e"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-tn"]
|
||
---
|
||
|
||
# Tennessee SB 2240 (112) — Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Amendment HA0790** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/112/Amend/HA0790.pdf)
|
||
2. **Amendment SA0754** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/112/Amend/SA0754.pdf)
|
||
3. **Current Version** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/112/Bill/SB2240.pdf)
|
||
|
||
## Votes
|
||
|
||
- HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 4/4/2022 3/31/2022 (2) — **0–0** (fail) · lower
|
||
- FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/4/2022 Passed (1) — **93–0** (pass) · lower
|
||
- HOUSE HEALTH SUBCOMMITTEE: Rec for pass if am by s/c ref. to Health Committee 3/15/2022 (4) — **0–0** (fail) · lower
|
||
- HOUSE HEALTH COMMITTEE: Rec. for pass. if am., ref. to Calendar & Rules Committee 3/23/2022 (3) — **0–0** (pass) · lower
|
||
- FLOOR VOTE: as Amended Third Consideration 3/31/2022 Passed (1) — **30–0** (pass) · upper
|
||
- SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0 3/23/2022 Passed (2) — **9–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Haile — primary (person)
|
||
- Vaughan — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2022-02-01** Filed for introduction `introduction, reading-1`
|
||
- **2022-02-01** Filed for introduction `introduction, reading-1`
|
||
- **2022-02-02** Introduced, Passed on First Consideration `introduction`
|
||
- **2022-02-02** Intro., P1C. `introduction`
|
||
- **2022-02-03** Passed on Second Consideration, refer to Senate Health and Welfare Committee
|
||
- **2022-02-03** P2C, ref. to Health Committee `referral-committee`
|
||
- **2022-02-07** Assigned to s/c Health Subcommittee `referral-committee`
|
||
- **2022-02-09** Sponsor(s) Added.
|
||
- **2022-03-02** Placed on Senate Health and Welfare Committee calendar for 3/9/2022
|
||
- **2022-03-02** Placed on s/c cal Health Subcommittee for 3/8/2022
|
||
- **2022-03-08** Action Def. in s/c Health Subcommittee to 3/15/2022
|
||
- **2022-03-09** Action deferred in Senate Health & Welfare Committee to next calendar
|
||
- **2022-03-09** Placed on s/c cal Health Subcommittee for 3/15/2022
|
||
- **2022-03-15** Rec for pass if am by s/c ref. to Health Committee `referral-committee`
|
||
- **2022-03-16** Placed on Senate Health and Welfare Committee calendar for 3/23/2022
|
||
- **2022-03-16** Placed on cal. Health Committee for 3/23/2022
|
||
- **2022-03-23** Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 9, Nays 0 PNV 0
|
||
- **2022-03-23** Sponsor(s) Added.
|
||
- **2022-03-23** Rec. for pass. if am., ref. to Calendar & Rules Committee `committee-passage-favorable`
|
||
- **2022-03-28** Placed on Senate Regular Calendar for 3/30/2022
|
||
- **2022-03-30** Placed on Senate Regular Calendar for 3/31/2022
|
||
- **2022-03-30** Senate Reset on calendar for 3/31/2022
|
||
- **2022-03-30** Placed on cal. Calendar & Rules Committee for 3/31/2022
|
||
- **2022-03-31** Engrossed; ready for transmission to House
|
||
- **2022-03-31** Passed Senate as amended, Ayes 30, Nays 0 `passage`
|
||
- **2022-03-31** Senate adopted Amendment (Amendment 1 - SA0754)
|
||
- **2022-03-31** H. Placed on Regular Calendar for 4/4/2022
|
||
- **2022-04-04** Passed H., Ayes 93, Nays 0, PNV 0 `passage`
|
||
- **2022-04-04** Am. withdrawn. (Amendment 1 - HA0790) `amendment-withdrawal`
|
||
- **2022-04-04** Subst. for comp. HB.
|
||
- **2022-04-04** Rcvd. from S., held on H. desk.
|
||
- **2022-04-04** Comp. SB subst.
|
||
- **2022-04-04** Sponsor(s) Added.
|
||
- **2022-04-05** Signed by Senate Speaker
|
||
- **2022-04-05** Enrolled and ready for signatures
|
||
- **2022-04-06** Signed by H. Speaker
|
||
- **2022-04-07** Transmitted to Governor for action.
|
||
- **2022-04-14** Signed by Governor. `executive-signature`
|
||
- **2022-04-26** Effective date(s) 04/14/2022
|
||
- **2022-04-26** Pub. Ch. 881
|
||
- **2022-04-26** Comp. became Pub. Ch. 881
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/ca27ad67-6053-443c-aa7b-ecef232244bc`. Confidence: reported (aggregated from official Tennessee legislature records).
|
||
|